Skip to content
★ Sign in to follow
AC

Anthony Caracciolo

Executive
CytoDyn Inc.
Total declarations
17
Company
1
▲ Purchases (2 ops.)
€72k
▼ Sales (0 ops.)
—

Latest filing published 19 Nov 2018 for CytoDyn Inc..

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+0.4%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 31 Oct 2014 · 4392 days ago · €15k
    +21.3%
    Entry US$0.75 · Close at T+365 US$0.91
  • Filed 22 Dec 2011 · 5436 days ago · €57k
    -65.5%
    Entry US$2.90 · Close at T+365 US$1.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Anthony Caracciolo: trading record in brief

Anthony Caracciolo appears in our data through filings on CytoDyn Inc. shares, published by SEC (Form 4). In total, 17 filings cover trades dated from 21 December 2011 to 16 November 2018.

Purchases make up the whole of the open-market record (2 purchases, €72k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 11 share grants.

The newest entry dates from 19 November 2018: a share grant, in CytoDyn Inc. The most recent open-market purchase was published on 31 October 2014, 4,392 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Anthony Caracciolo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations